Pharmidex provides GLP/GCP compliant analytical services for preclinical and clinical development, covering PK, TK and biomarkers.
May 22, 2024
Our highly experienced bioanalytical team is trained for GCP, GLP and non-GLP studies, ensuring efficiency and regulatory compliance.
Find out more by visiting our website
https://lnkd.in/erYFwZxH or contact us at
[email protected] to discuss your requirements.
#glp #gcp #goodlaboratorypractice #goodclinicalpractice #contractresearchorganisation #cro #pharmidex #bioanalysis #drugdiscovery #drugdevelopment #collaboration #preclinical #biomarkers #lifescience
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
